FR EA

Matter 1013-00001 — Genome Dx Therapeutics Inc

2026 · 12 documents · Finance & Banking · C. Fontaine

38.4hours logged
$9,200unbilled WIP
$26,900billed to date
DateLawyerDescription HoursAmount
2026-02-13 M. Sage Conference call re borrowers counsel legal opinion 3.2 $3,008
2026-02-22 S. Beaumont Review and annotate closing checklist 2.0 $1,880
2026-03-03 E. Alder Draft and revise funds flow memorandum 4.4 $4,136
2026-03-03 J. Whitfield Legal research re officers certificate 1.8 $1,692
2026-03-17 R. Okafor Conference call re closing letter to client 4.3 $4,042
2026-03-30 C. Fontaine Review and annotate internal memo deal summary key issues 1.8 $1,692
2026-03-09 S. Beaumont Analyze bridge loan agreement execution 1.1 $1,034
2026-04-17 D. Lindqvist Conference call re intercreditor agreement execution 2.8 $2,632
2026-03-09 E. Alder Draft and revise ip security agreement execution 2.3 $2,162
2026-03-30 R. Okafor Conference call re security agreement execution 1.4 $1,316
2026-04-24 J. Whitfield Correspondence re warrant agreement cobalt 3.1 $2,914
2026-05-01 C. Fontaine Legal research re warrant agreement pinnacle 3.9 $3,666
Invoice preview 38.4 $9,200